Position in ACRV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$73,471
-$3,883,468 QoQ
Shares Held
41,276
-97.5% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 46 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. ACRV ranks #367 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in ACRV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,471 | 41,276 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $3,956,939 | 1,641,884 | Shares | Defined | 2026-02-17 | |
| 2025-11-14 | $3,856,982 | 1,721,867 | Shares | Sole | 2025-11-21 | |
| 2025-09-30 | $2,789,800 | 1,541,326 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,255,667 | 1,895,519 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,847,903 | 1,895,519 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,760,268 | 2,119,646 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,984,396 | 2,140,628 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,293,946 | 2,119,646 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,012,192 | 1,680,027 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,116,321 | 1,649,659 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $15,778,368 | 1,650,457 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $21,379,412 | 1,649,646 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $20,824,568 | 1,641,022 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $18,824,878 | 1,634,104 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||